Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 51, Number 8, 1 August 2011

< previous issue | all issues | next issue >

In this issue
pp. 1643-1643(1)

Does the storage duration of blood products affect outcomes in critically ill patients?
pp. 1644-1650(7)
Authors: Spinella, Philip C.; Doctor, Allan; Blumberg, Neil; Holcomb, John B.

Dengue: a potential transfusion‐transmitted disease
pp. 1654-1660(7)
Authors: Tomashek, Kay M.; Margolis, Harold S.

An old‐fashioned transfusion
pp. 1661-1661(1)
Authors: Lefrère, Jean‐Jacques

Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction
pp. 1676-1683(8)
Authors: Tobian, Aaron A.R.; Savage, William J.; Tisch, Daniel J.; Thoman, Sandra; King, Karen E.; Ness, Paul M.

The appropriateness of red blood cell use and the extent of overtransfusion: right decision? Right amount?
pp. 1684-1694(11)
Authors: Barr, Paul J.; Donnelly, Michael; Cardwell, Chris R.; Parker, Michael; Morris, Kieran; Bailie, Karen E.M.

A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients
pp. 1695-1706(12)
Authors: Solomon, Cristina; Cadamuro, Janne; Ziegler, Bernhard; Schöchl, Herbert; Varvenne, Michael; Sørensen, Benny; Hochleitner, Gerald; Rahe‐Meyer, Niels

Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study
pp. 1707-1715(9)
Authors: Pottgiesser, Torben; Sottas, Pierre‐Edouard; Echteler, Tobias; Robinson, Neil; Umhau, Markus; Schumacher, Yorck Olaf

Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes
pp. 1716-1722(7)
Authors: Savage, William J.; Tobian, Aaron A.; Fuller, Alice K.; Wood, Robert A.; King, Karen E.; Ness, Paul M.

Modeling transfusion reactions and predicting in vivo cell survival with kodecytes
pp. 1723-1730(8)
Authors: Oliver, Caroline; Blake, Deborah; Henry, Stephen

Continuing Medical Education Program in
pp. 1731-1731(1)
Author: Eder, Anne F.

Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14‐year experience from a single center (CME)
pp. 1732-1739(8)
Authors: LaSalle‐Williams, Michele; Nuss, Rachelle; Le, Tuan; Cole, Laura; Hassell, Kathy; Murphy, James R.; Ambruso, Daniel R.

Antibodies to oxaliplatin, a chemotherapeutic, are found in plasma of healthy blood donors
pp. 1740-1744(5)
Authors: Leger, Regina M.; Garratty, George

A new platelet alloantigen, Swi
pp. 1745-1754(10)
Authors: Kroll, Hartmut; Feldmann, Korinna; Zwingel, Claudia; Hoch, Jochen; Bald, Rainer; Bein, Gregor; Bayat, Behnaz; Santoso, Sentot

Fukuoka‐1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow–derived cells with features of mesenchymal stem cells
pp. 1755-1768(14)
Authors: Cervenakova, Larisa; Akimov, Sergey; Vasilyeva, Irina; Yakovleva, Oksana; McKenzie, Carroll; Cervenak, Juraj; Piccardo, Pedro; Asher, David M.

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation
pp. 1769-1778(10)
Authors: Nguyen, Stéphanie; Béziat, Vivien; Norol, Françoise; Uzunov, Madalina; Trebeden‐Negre, Hélène; Azar, Nabih; Boudifa, Ali; Bories, Dominique; Debré, Patrice; Vernant, Jean‐Paul; Vieillard, Vincent; Dhédin, Nathalie

A randomized clinical trial comparing granulocyte–colony‐stimulating factor administration sites for mobilization of peripheral blood stem cells for patients with hematologic malignancies undergoing autologous stem cell transplantation
pp. 1779-1783(5)
Authors: Renfroe, Heather; Arnold, Mike; Vaughn, Louette; Harvey, R. Donald; Hamilton, Ellie; Lonial, Sagar; Khoury, H. Jean; Kaufman, Jonathan L.; Lechowicz, Mary Jo; Flowers, Christopher R.; Waller, Edmund K.

The low viability of human CD34+ cells under acidic conditions is improved by exposure to thrombopoietin, stem cell factor, interleukin‐3, or increased cyclic adenosine monophosphate levels
pp. 1784-1795(12)
Authors: D'Atri, Lina Paola; Etulain, Julia; Romaniuk, María Albertina; Torres, Oscar; Negrotto, Soledad; Schattner, Mirta

Enhancing blood donation intentions using multimedia donor education materials
pp. 1796-1801(6)
Authors: France, Christopher R.; France, Janis L.; Wissel, Mary Ellen; Kowalsky, Jennifer M.; Bolinger, Elizabeth M.; Huckins, Jamie L.

Effect of applied muscle tension on cerebral oxygenation in female blood donors
pp. 1802-1808(7)
Authors: Kowalsky, Jennifer M.; France, Janis L.; Wissel, Mary Ellen; France, Christopher R.

Barriers to blood donation in African communities in Australia: the role of home and host country culture and experience
pp. 1809-1819(11)
Authors: Polonsky, Michael Jay; Renzaho, André M.N.; Brijnath, Bianca

Healthy donor effect: its magnitude in health research among blood donors
pp. 1820-1828(9)
Authors: Atsma, Femke; Veldhuizen, Ingrid; Verbeek, André; de Kort, Wim; de Vegt, Femmie

Donor understanding and attitudes about current and potential deferral criteria for high‐risk sexual behavior
pp. 1829-1834(6)
Authors: Goldman, Mindy; Yi, Qi‐Long; Ye, Xibiao; Tessier, Lorna; O'Brien, Sheila F.

Effect on the quality of blood components after simulated blood transfusions using volumetric infusion pumps
pp. 1835-1839(5)
Authors: Lieshout‐Krikke, Ryanne W.; van der Meer, Pieter F.; Koopman, Maria M.W.; de Korte, Dirk

Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors
pp. 1840-1846(7)
Authors: Seo, Dong Hee; Whang, Dong Hee; Song, Eun Young; Kim, Hyun Soo; Park, Quehn

Pitfalls in the current published observational literature on the effects of red blood cell storage
pp. 1847-1854(8)
Authors: van de Watering, Leo; for the Biomedical Excellence for Safer Transfusion (BEST) Collaborativecr2

FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety
pp. 1855-1871(17)
Authors: Atreya, Chintamani; Nakhasi, Hira; Mied, Paul; Epstein, Jay; Hughes, James; Gwinn, Marta; Kleinman, Steven; Dodd, Roger; Stramer, Susan; Walderhaug, Mark; Ganz, Peter; Goodrich, Raymond; Tibbetts, Clark; Asher, David

Sporadic Creutzfeldt‐Jakob disease and risk of blood transfusion in the United Kingdom
pp. 1872-1873(2)
Authors: Molesworth, Anna M.; Mackenzie, Jan; Everington, Dawn; Knight, Richard S.G.; Will, Robert G.

In reply
pp. 1873-1874(2)
Authors: Puopolo, Maria; Ladogana, Anna; Vetrugno, Vito; Pocchiari, Maurizio

ABO‐immunoglobulin G antibodies in intravenous immune globulin can interfere in ABO‐mismatched kidney transplants
pp. 1874-1875(2)
Authors: Boctor, Fouad N.; BhasKaran, Madhu; Sheahan, Bridget; Heaton, W.A.; Molmenti, Ernesto

Conditions for plasma processing
pp. 1875-1876(2)
Authors: Farrugia, Albert; Prowse, Chris V.; Hornsey, Valerie Scott

In reply
pp. 1876-1876(1)
Author: Cardigan, Rebecca

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page